Variant report
Variant | nsv947884 |
---|---|
Chromosome Location | chr10:43051168-43067229 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:33)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:33 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr10:43052572-43052664 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr10:43051301-43051501 | HepG2 | liver: | n/a | n/a |
3 | CTCF | chr10:43062280-43062430 | HepG2 | liver: | n/a | n/a |
4 | CTCF | chr10:43057653-43057682 | GM10266 | blood: | n/a | n/a |
5 | FOXA1 | chr10:43052403-43052701 | HepG2 | liver: | n/a | n/a |
6 | FOXA2 | chr10:43052431-43052713 | HepG2 | liver: | n/a | n/a |
7 | HDAC2 | chr10:43052391-43052705 | HepG2 | liver: | n/a | n/a |
8 | HEY1 | chr10:43052339-43052700 | HepG2 | liver: | n/a | n/a |
9 | HNF4A | chr10:43052426-43052743 | HepG2 | liver: | n/a | chr10:43052573-43052586 chr10:43052572-43052585 chr10:43052570-43052588 chr10:43052572-43052586 chr10:43052574-43052586 chr10:43052571-43052586 chr10:43052572-43052585 chr10:43052573-43052585 chr10:43052573-43052585 chr10:43052568-43052590 chr10:43052573-43052585 chr10:43052572-43052586 chr10:43052572-43052585 chr10:43052573-43052585 chr10:43052572-43052586 |
10 | HNF4A | chr10:43052392-43052697 | HepG2 | liver: | n/a | chr10:43052573-43052586 chr10:43052572-43052585 chr10:43052570-43052588 chr10:43052572-43052586 chr10:43052574-43052586 chr10:43052571-43052586 chr10:43052572-43052585 chr10:43052573-43052585 chr10:43052573-43052585 chr10:43052568-43052590 chr10:43052573-43052585 chr10:43052572-43052586 chr10:43052572-43052585 chr10:43052573-43052585 chr10:43052572-43052586 |
11 | HNF4G | chr10:43052410-43052667 | HepG2 | liver: | n/a | chr10:43052573-43052586 chr10:43052572-43052585 chr10:43052570-43052588 chr10:43052572-43052586 chr10:43052574-43052586 chr10:43052572-43052585 chr10:43052573-43052585 chr10:43052573-43052585 chr10:43052568-43052590 chr10:43052573-43052585 chr10:43052572-43052586 chr10:43052572-43052585 chr10:43052573-43052585 chr10:43052572-43052586 chr10:43052570-43052585 |
12 | KAP1 | chr10:43057093-43057647 | U2OS | brain: | n/a | n/a |
13 | KAP1 | chr10:43065961-43066152 | HEK293 | kidney: | n/a | n/a |
14 | MAFF | chr10:43054785-43054970 | HepG2 | liver: | n/a | n/a |
15 | MAFK | chr10:43061410-43061572 | HepG2 | liver: | n/a | n/a |
16 | MAFK | chr10:43054783-43055044 | HepG2 | liver: | n/a | n/a |
17 | MAFK | chr10:43051147-43051463 | HepG2 | liver: | n/a | n/a |
18 | MAFK | chr10:43054796-43055029 | HepG2 | liver: | n/a | n/a |
19 | MAFK | chr10:43053003-43053035 | HepG2 | liver: | n/a | n/a |
20 | MAFK | chr10:43051143-43051351 | HepG2 | liver: | n/a | n/a |
21 | MAX | chr10:43052470-43052706 | K562 | blood: | n/a | n/a |
22 | MAX | chr10:43052326-43052737 | HepG2 | liver: | n/a | n/a |
23 | MAX | chr10:43052383-43052902 | HepG2 | liver: | n/a | n/a |
24 | MAZ | chr10:43052637-43052837 | HepG2 | liver: | n/a | n/a |
25 | MXI1 | chr10:43052490-43052710 | HepG2 | liver: | n/a | n/a |
26 | MYC | chr10:43052561-43052705 | HepG2 | liver: | n/a | n/a |
27 | POLR2A | chr10:43060615-43060851 | GM12878 | blood: | n/a | n/a |
28 | POLR2A | chr10:43052409-43052576 | HepG2 | liver: | n/a | n/a |
29 | POLR2A | chr10:43056895-43057048 | GM12878 | blood: | n/a | n/a |
30 | RXRA | chr10:43052422-43052704 | HepG2 | liver: | n/a | chr10:43052572-43052585 chr10:43052577-43052586 chr10:43052571-43052585 chr10:43052572-43052585 chr10:43052571-43052587 chr10:43052572-43052585 chr10:43052569-43052589 |
31 | SMC3 | chr10:43053041-43053095 | HepG2 | liver: | n/a | n/a |
32 | SRF | chr10:43062519-43062610 | GM12878 | blood: | n/a | n/a |
33 | STAT3 | chr10:43061111-43061508 | MCF10A-Er-Src | breast: | n/a | chr10:43061433-43061444 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:43048254..43049868-chr10:43050241..43052640,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZNF37BP | TF binding region |
EIF3LP2 | TF binding region |
ENSG00000234420 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184709533 | chr10:43051191-43051192 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs145410945 | chr10:43051262-43051263 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs188814562 | chr10:43051282-43051283 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs569391794 | chr10:43051302-43051303 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs560011238 | chr10:43051381-43051382 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs370177324 | chr10:43051426-43051427 | Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs527433209 | chr10:43051428-43051429 | Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs142636618 | chr10:43051437-43051438 | Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs564347060 | chr10:43051530-43051531 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs371741508 | chr10:43051549-43051550 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs531505261 | chr10:43051557-43051558 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs550128164 | chr10:43051568-43051569 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs11306632 | chr10:43051580-43051581 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs568452302 | chr10:43051694-43051695 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs529323525 | chr10:43051715-43051716 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs547886783 | chr10:43051716-43051717 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs111449363 | chr10:43051717-43051718 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs78225062 | chr10:43051739-43051740 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs371235913 | chr10:43051744-43051745 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs35361871 | chr10:43051786-43051787 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs192076238 | chr10:43051826-43051827 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs539962172 | chr10:43051832-43051833 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs558063212 | chr10:43051834-43051835 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs1147903 | chr10:43051835-43051836 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs145441655 | chr10:43051860-43051861 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs184432811 | chr10:43051863-43051864 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs574065704 | chr10:43051887-43051888 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs200404738 | chr10:43051932-43051933 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs577578529 | chr10:43051936-43051937 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs541426946 | chr10:43051941-43051942 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs553788565 | chr10:43051970-43051971 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs111823822 | chr10:43051979-43051980 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs370455134 | chr10:43052036-43052037 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs376661324 | chr10:43052046-43052047 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs540212999 | chr10:43052048-43052049 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs375283365 | chr10:43052064-43052065 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs564105964 | chr10:43052066-43052067 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs113503038 | chr10:43052115-43052116 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs372910187 | chr10:43052145-43052146 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs552045217 | chr10:43052169-43052170 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs571180896 | chr10:43052222-43052223 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs561986197 | chr10:43052285-43052286 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs114218883 | chr10:43052336-43052337 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs533526768 | chr10:43052354-43052355 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs148856165 | chr10:43052355-43052356 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs549364963 | chr10:43052385-43052386 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs34303833 | chr10:43052387-43052388 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs58355620 | chr10:43052388-43052389 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs61622828 | chr10:43052391-43052392 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs189130265 | chr10:43052422-43052423 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 22241247 | CNVD |
Intellectual disability | 21811512 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Obesity | 21956041 | CNVD |
Lung cancer | 21569311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21785460 | CNVD |
Autism | 20531469 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:43048800-43052200 | Weak transcription | Lung | lung |
2 | chr10:43049200-43052400 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
3 | chr10:43050800-43051200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr10:43050800-43051400 | Enhancers | HepG2 | liver |
5 | chr10:43051400-43052600 | Flanking Active TSS | HepG2 | liver |
6 | chr10:43052200-43052600 | Enhancers | Lung | lung |
7 | chr10:43052400-43052600 | Enhancers | Rectal Mucosa Donor 29 | rectum |
8 | chr10:43052600-43053400 | Enhancers | HepG2 | liver |
9 | chr10:43053400-43056800 | Weak transcription | HepG2 | liver |
10 | chr10:43055400-43057000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr10:43056400-43056800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr10:43056400-43058000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr10:43056600-43056800 | Enhancers | Fetal Kidney | kidney |
14 | chr10:43056800-43057400 | Enhancers | HepG2 | liver |
15 | chr10:43057000-43057800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr10:43057400-43057600 | Enhancers | Fetal Kidney | kidney |
17 | chr10:43058000-43058600 | Enhancers | Primary B cells from peripheral blood | blood |